Cervical human papillomavirus infection in women attending gynaecological outpatient clinics in northern Greece

European Journal of Cancer Prevention

Volumn 13, Issue 2, 2004, Pages 145-147

  Agorastos, T ^a   Dinas, K ^a   Lloveras, B ^b   Bosch, F X ^c   Kornegay, J R ^d   Bontis, J N ^a   De Sanjose, S ^c  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c Institut Catalan d'Oncologia   (Spain)

^d ROCHE MOLECULAR SYSTEMS   (United States)

Author keywords

Cervical intraepithelial lesions; Greece; Human papillomavirus; Prevalence

Indexed keywords

VIRUS DNA;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CONFIDENCE INTERVAL; FEMALE; GREECE; HUMAN; HUMAN CELL; INFECTION RISK; INTERVIEW; MAJOR CLINICAL STUDY; NULLIPARA; OUTPATIENT DEPARTMENT; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; UTERINE CERVIX; UTERINE CERVIX CARCINOMA IN SITU; VIRUS INFECTION; WART VIRUS;

EID: 2342613053     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008469-200404000-00010     Document Type: Article

References (16)

1. Agorastos T (2002). Clinical importance of HPV-test or the lost game with time. Hellenic J Gynaecol Obstet 1: 349.
2. Agorastos T, Bontis J, Lambropoulos AF, et al. (1995). Epidemiology of human papillomavirus infection in Greek asymptomatic women. Eur J Cancer Prev 4: 159-167.
3. Anastasiadis PG, Koutlaki NG, Liberis VA (2000). Trends in epidemiology of cervical cancer in Thrace, Greece. Int J Gynaecol Obstet 68: 59-60.
4. Ann PT, Hieu NT, Herrero R, et al. (2003). Human papillomavirus infection among women in South and North Vietnam. Int J Cancer 104: 213-220.
5. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV (2002). The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55: 244-265.
6. Constantinidis TC, Benos A, Agorastos T (2003). Geographical differences in epidemiological parameters of gynecological cancer in Greece and necessity of existence of a cancer registry. In: Agorastos T, Bontis J (editors): Prevention of Gynecological Cance, Thessaloniki: University Studio Press. pp. 47-63.
7. de Sanjose S, Almirall MR, Lloveras B, et al. (2003). Cervical Human papillomavirus infection in the female population in Barcelona, Spain. Sex Transm Dis 30: 788-793.
8. Gravitt PE, Peyton CL, Apple RJ, Wheeler CM (1998). Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol 36: 3020-3027.
9. Gravitt PE, Peyton CL, Alessi TQ, et al. (2000). Improved amplification of genital human papillomaviruses. J Clin Microbiol 38: 357-361.
10. Herrero R, Hildesheim A, Bratti C, et al. (2000). Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 92: 464-474.
11. Kornegay JR, Shepard AP, Hankins C, et al. (2001). Nonisotopic detection of human papillomavirus DNA in clinical specimens using a consensus PCR and a generic probe mix in an enzyme-linked immunosorbent assay format. J Clin Microbiol 39: 3530-3536.
12. Molano M, Posso H, Weiderpass E, et al. (2002). Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br J Cancer 87: 324-333.
13. Munoz N, Bosch FX, de Sanjose S, et al. (2003). Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348: 518-527.
14. Sellors JW, Mahony JB, Kaczorowski J, et al. (2000). Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. Survey of HPV in Ontario Women (SHOW) Group. Can Med Assoc J 163: 503-508.
15. Shin HR, Lee DH, Herrero R, et al. (2003). Prevalence of human papillomavirus infection in women in Busan, South Korea. Int J Cancer 103: 413-421.
16. Wright TC Jr, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ (2002). 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA 287: 2120-2129.